Evidence map›Paper›PMID 41378333›Full record

ArticleWorld journal of gastroenterology2025

Machine learning to predict metabolic-associated fatty liver disease.

Ottavia Cicerone, Marcello Maestri

Abstract readLetter
In one paragraph

Article in World journal of gastroenterology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ottavia CiceroneDepartment of Clinical-Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Pavia 27100, Italy.
Marcello MaestriGeneral Surgery Unit I - Liver Service, Fondazione IRCCS Policlinico San Matteo, Pavia 27100, Italy. m.maestri@smatteo.pv.it.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metabolic-associated fatty liver disease (MAFLD) represents the most common cause of chronic liver disease worldwide and remains frequently underdiagnosed in its early stages. Tian

Indexed as

Fatty LiverMachine LearningNon-alcoholic Fatty Liver DiseaseAlanine TransaminaseBiomarkersEarly DiagnosisHumansLiverMedicine, Chinese TraditionalPredictive Value of TestsProspective StudiesAlanine TransaminaseBiomarkersChronic liver diseaseHepatic steatosisMachine learningMetabolic-associated fatty liver diseasePredictive model

Identifiers

PMID41378333
PMCPMC12686992

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.